Ray M. Lowenthal

17 Liverpool Street
Hobart, TAS 7000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Evaluating a CLL susceptibility variant in ITGB2 in families with multiple subtypes of hematological malignancies.

Evaluating a CLL susceptibility variant in ITGB2 in families with multiple subtypes of hematological malignancies.

Journal: Blood

Published: May 12, 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 04, 2017

The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.

The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.

Journal: Integrative cancer therapies

Published: December 23, 2016

Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.

Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.

Journal: Oncotarget

Published: March 17, 2016

Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo.

Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo.

Journal: Journal of cellular physiology

Published: June 12, 2015

Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.

Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.

Journal: Marine drugs

Published: February 24, 2015

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 05, 2014

A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study.

A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study.

Journal: Oncology reports

Published: September 03, 2014

Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship.

Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship.

Journal: Internal medicine journal

Published: May 08, 2014

Use of 'rainy day' autologous haemopoietic stem cells: a single-institution experience over 10 years.

Use of 'rainy day' autologous haemopoietic stem cells: a single-institution experience over 10 years.

Journal: Internal medicine journal

Published: January 03, 2014

The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation.

The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: August 24, 2013

Lymphoma studies by the Australasian Leukaemia and Lymphoma Group.

Lymphoma studies by the Australasian Leukaemia and Lymphoma Group.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: August 22, 2013

Showing 1-12 of 21

Last Updated: 09/26/2026